BioSpace News Archive

Activities will cover emerging strategies and pressing challenges faced by the breast cancer community

The Company had been unable to secure the necessary financing to advance the development of the HeartSentry technology including the payment of the minimum annual royalty fees due, in August 2018 and August 2019, to the Lawrence Berkeley National Laboratories.

The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares payable April 17, 2020 to shareholders of record on April 3, 2020.

Today, Medic Mobile announced the creation of Medic Labs, a new global health technology accelerator, with $3 million in seed funding from The Rockefeller Foundation.

Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ COVID-19 Test technical file has been submitted for registration with the European Community, and that it is expected to be available later this month as an in vitro diagnostic (“IVD”) for markets that accept a CE marking as valid regulatory approval.

The John D. and Catherine T. MacArthur Foundation announced that The National Council for Behavioral Health submitted one of the highest-scoring proposals in its global competition for a $100 million grant.

MemorialCare’s Long Beach Medical Center and Miller Children’s & Women’s Hospital Long Beach announced that sixteen of its physicians have been recognized as top doctors by the Orange Coast Magazine’s annual Top Doctors list.

Orgenesis Inc. (NASDAQ: ORGS), a provider of point-of-care cell and gene therapy development, processing and treatment solutions (“POCare”), today announced that it has entered into a collaboration agreement with the John Hopkins University (“JHU”) to utilize Orgenesis’ Point-of-Care (POCare) platform to develop and supply a variety of cell and gene therapies and technologies, including cell-based immunotherapy technologies

Adaptimmune Therapeutics plc, a leader in cell therapy to treat cancer, will report financial results for the Full Year / Fourth Quarter 2019 and provide a business update, before the U.S. markets open on Thursday, February 27, 2020.

TransMedics Group, Inc. announced the company will be participating in the upcoming Cowen 40th Annual Health Care Conference in Boston.